LIFEXP Nattokinase + Lumbrokinase is a dual-enzyme formulation designed to support cardiovascular health, enhance microcirculatory flow, and assist in the safe breakdown of excess fibrin. These proteolytic enzymes exhibit fibrinolytic, anti-inflammatory, and biofilm-disrupting properties, making them powerful agents in systemic health, vascular recovery, and adjunctive care for chronic inflammatory and circulatory conditions.
• Nattokinase is a single enzyme derived from natto, a traditional Japanese fermented soybean product (Bacillus subtilis natto).
• Lumbrokinase is a complex of fibrinolytic enzymes extracted from the earthworm Lumbricus rubellus, known for its multi-targeted enzymatic activity and superior stability.
OVERVIEWLIFEXP Nattokinase + Lumbrokinase is a dual-enzyme formulation designed to support cardiovascular health, enhance microcirculatory flow, and assist in the safe breakdown of excess fibrin. These proteolytic enzymes exhibit
fibrinolytic, anti-inflammatory, and
biofilm-disrupting properties, making them powerful agents in systemic health, vascular recovery, and adjunctive care for chronic inflammatory and circulatory conditions.
•
Nattokinase is a single enzyme derived from
natto, a traditional Japanese fermented soybean product (
Bacillus subtilis natto).
•
Lumbrokinase is a complex of fibrinolytic enzymes extracted from the earthworm
Lumbricus rubellus, known for its
multi-targeted enzymatic activity and
superior stability.
Key Features and Clinical ActionsFibrinolytic Activity• Both enzymes actively
break down fibrin, a protein that contributes to blood clot formation and vascular obstruction.
• Lumbrokinase supports
plasminogen activation, enhancing the body’s ability to naturally dissolve clots.
Microcirculatory & Anti-Inflammatory Effects• Improves
blood viscosity, oxygen delivery, and capillary perfusion.
• Reduces
cell adhesion and inflammation, supporting vascular recovery post-surgery or post-infection.
Broader Therapeutic Potential•
Lumbrokinase has been studied for potential anti-tumor activity, especially in reducing metastasis and tumor cell adhesion.
• May support
wound healing and
tissue regeneration by modulating inflammation and promoting healthy circulation.
Ophthalmologic ApplicationsThe combination offers emerging promise in managing
vascular-related eye conditions through fibrinolytic and anti-inflammatory pathways:
1.
Retinal Vein Occlusion (RVO) – May assist in reducing fibrin load and restoring retinal perfusion.
2.
Diabetic Retinopathy – May improve microvascular circulation and reduce endothelial stress.
3.
Glaucoma – May provide adjunctive optic nerve support through enhanced blood flow and mitochondrial defense.
Biofilm Disruption Activity•
Nattokinase interferes with the
extracellular matrix of bacterial biofilms, particularly against
Streptococcus mutansand
Enterococcus faecalis.
•
Lumbrokinase contributes to
biofilm dismantling, which may enhance treatment of chronic infections associated with biofilm resistance.
FEATURES• Promotes healthy blood viscosity and circulatory flow
• Supports fibrinolytic activity to help break down excess fibrin
• May aid in recovery from inflammation-related vascular damage
• Enhances nutrient and oxygen delivery to tissues and organs
• Useful as a systemic enzyme in post-viral, sedentary, or aging populations
Ideal For:• Adults with cardiovascular risk factors or sedentary lifestyles
• Post-inflammatory or post-viral vascular support
• Individuals recovering from long flights or immobilization
- • Those seeking proactive vascular longevity support
DIRECTION OF USEGeneral Support Dose:Take
1 capsule once daily on an
empty stomach, at least
1 hour before or
2 hours after meals. Best taken in the morning or midday.
Therapeutic Dose (Practitioner-Guided):Take
1 capsule twice daily, morning and mid-afternoon, on an empty stomach.
Recommended for individuals with increased fibrin burden, sluggish circulation, or recovering from vascular stress (e.g., travel, inflammation, immobilization).
Note:Do not use with anticoagulant or antiplatelet medications unless under supervision. Discontinue 5–7 days before surgery.